JPS61267521A - Agent for controlling saprolegniasis and capsulated-pseudomonas disease of carp - Google Patents
Agent for controlling saprolegniasis and capsulated-pseudomonas disease of carpInfo
- Publication number
- JPS61267521A JPS61267521A JP8824986A JP8824986A JPS61267521A JP S61267521 A JPS61267521 A JP S61267521A JP 8824986 A JP8824986 A JP 8824986A JP 8824986 A JP8824986 A JP 8824986A JP S61267521 A JPS61267521 A JP S61267521A
- Authority
- JP
- Japan
- Prior art keywords
- carp
- kasugamycin
- saprolegniasis
- capsulated
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、−にスガマイシンまたはその塩類(たとえば
塩酸塩−以下これらをカスガマイシンという)を有効成
分として含有することを特徴とするコイの水かび病、細
菌性白雲症防除剤に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for controlling water mold and bacterial white cloud disease of carp, which is characterized by containing sugamycin or its salts (for example, hydrochloride, hereinafter referred to as kasugamycin) as an active ingredient. Regarding drugs.
カスガマイシンは、ストレプトミセス・カスガエンシス
と命名された放線菌の生産する抗生物質であり(特公昭
42−6818号公報)、イネいもち病に対し特効的な
治療効果を有しているため、農業用殺菌剤として実用化
されている。Kasugamycin is an antibiotic produced by an actinomycete named Streptomyces kasugaensis (Japanese Patent Publication No. 6818/1983), and has a specific therapeutic effect on rice blast, so it is used for agricultural purposes. It is put into practical use as a disinfectant.
本発明者らは、コイに発生する水かび病、細菌性白雲症
に対し有効な薬剤を開発する目的で種々の薬剤について
スクリーニングを行った。その結果、カスガマイシンが
シ゛ニー、トモナス菌による細菌性白雲症、サブロレグ
ニア菌による水カビ病などに極めて有効であることを見
出した0本発明によれば、カスガマイシンを使用してこ
れら病菌によるコイの水かび病、細菌性白雲症を経済的
且つコイに薬害を4えることなく完治する方法が提供さ
れる。The present inventors screened various drugs for the purpose of developing drugs effective against water mold and bacterial white cloud disease occurring in carp. As a result, it has been found that kasugamycin is extremely effective against bacterial leucobia caused by carp, Tomonas bacterium, and water mold caused by Sabrolegnia. To provide a method for completely curing carp disease, bacterial leucoriasis, economically and without causing chemical damage to carp.
コイは1重要な蛋白資源であるために、近年天然資源保
護の見地より自然無法と併用して養殖魚法が漸次盛んに
なってきている。しかしながら。Since carp is an important protein resource, in recent years, fish farming methods have been gradually gaining popularity in conjunction with natural methods from the viewpoint of natural resource protection. however.
養殖魚法の場合は、限られた面棲内て比較的多数の個体
を飼養するために、各種の疾病に患りゃすい、そのため
、これらの疾病を対象として種々の抗生物質を含む抗菌
剤が使用されているが、これらの中には人の疾病にも使
用されるものが含まれており、耐性菌の別層などを考え
ると必ずしも好ましくない。In the case of farmed fish, because a relatively large number of fish are kept in a limited habitat, they are susceptible to various diseases, so antibacterial agents including various antibiotics are used to treat these diseases. However, some of these are also used for human diseases, which is not necessarily desirable considering the possibility of another layer of resistant bacteria.
カスガアイシンは、イネいもち病防除剤として開発され
た薬剤で現在いもち病防除剤として広く使用されており
、その毒性は極めて低く、慢性毒性も認められない、ま
たカスガマイシンは、動物体内では比較的速かに排泄さ
れ、自然環境内においても分解されることが確認されて
おり、極めて安全な薬剤である。Kasugaisin is a drug developed as a rice blast control agent, and is currently widely used as a rice blast control agent. Its toxicity is extremely low, and no chronic toxicity is observed. Also, kasugamycin is released relatively quickly in the animal body. It has been confirmed that it is excreted by crabs and decomposed in the natural environment, making it an extremely safe drug.
一般に行われている寒天希釈法で、コイに感染する水か
び病菌に対してカスガマイシンの最低発育阻止濃度をし
らべた。その結果を第1表に示した。Using the commonly used agar dilution method, we determined the minimum inhibitory concentration of kasugamycin against the water mold fungus that infects carp. The results are shown in Table 1.
第 1 表
コイ水かび病 注1) 31.3注1)供試菌
鉦法出上]■■■旦」(サブロレグニア パラシチカ)
注2)培養は20℃、48時間行った。Table 1 Carp water mold Note 1) 31.3 Note 1) Test bacteria
Note 2) Cultivation was carried out at 20°C for 48 hours.
注3)培地組成は次のとおりである。Note 3) The medium composition is as follows.
肉エキス 0.5%
ポリペプトン 0.3%
寒天束 1.2%
pH7,0
またカスガマイシンの水産動物に対する半数致死濃度は
、コイ、ワキシ、ヒメダカ、ドジョウ、オタマジャクシ
、ミジンコおよびタマミジンコのいずれに対しても11
000pp以上であり、極めて魚毒性が低い、そのため
、比較的高濃度の薬剤処理を行ってもこれを含む排水等
によりコイなどの水産動物が汚染されたり、死亡したり
する心配がなく、コイに対して薬害を与えることなく所
期の安全性が高く十分な治療効果をあげることができる
。Meat extract 0.5% Polypeptone 0.3% Agar bundle 1.2% pH 7.0 Furthermore, the half-lethal concentration of kasugamycin for aquatic animals is 100% for carp, waxfish, Japanese medaka, loach, tadpole, daphnia, and Daphnia daphnia. 11
000 pp or more, and has extremely low toxicity to fish.Therefore, even if a relatively high concentration of chemical treatment is performed, there is no worry that aquatic animals such as carp will be contaminated or die from wastewater containing the chemical, and it is safe for carp. It is possible to achieve the expected safety and sufficient therapeutic effect without causing any drug damage.
カスガマイシンを用いてコイの疾病を治療する方法とし
ては、カスガマイシン単独の薬液中にコイを薬浴せしめ
るか、または池あるいはその他の槽中に一定濃度になる
ように溶解して用いればよく、さらにニトロフラン系薬
剤などの他の薬剤と併用することもできる。またカスガ
マイシンを飼料中に混合して経口投与することもできる
。Kasugamycin can be used to treat carp diseases by bathing the carp in a solution of kasugamycin alone, or by dissolving it in a pond or other tank at a constant concentration. It can also be used in combination with other drugs such as furan drugs. Kasugamycin can also be mixed into feed and administered orally.
次に本発明の薬剤がコイの疾病に対して優れた治療効果
を有することを実施例により示す。Next, Examples show that the drug of the present invention has an excellent therapeutic effect on carp diseases.
なお、治療効果は次式により算出した。The therapeutic effect was calculated using the following formula.
治療生存点数(尾)
供試負数(尾)
(実施例1)
50iの清水(水温的22’C)を入れたタンクの中に
カスガマイシンを入れて、濃度が0.05%、0.04
%、0.02%および0.01%となるように溶解した
。そして、そこへ細菌性白雲症に感染したコイを16尾
入れて24時間薬浴させた。そして清水(水温的22℃
)中で7日間飼養した後、その治療効果を調査した。そ
の結果を第2表に示した。Treatment survival score (tail) Test negative number (tail) (Example 1) Kasugamycin was placed in a tank containing 50 i fresh water (water temperature 22'C), and the concentration was 0.05% and 0.04.
%, 0.02% and 0.01%. Then, 16 carp infected with bacterial albinism were placed there and bathed in medicine for 24 hours. And fresh water (water temperature 22℃
) for 7 days, the therapeutic effect was investigated. The results are shown in Table 2.
第 2 表
(実施例2)
50見の清水(水温的22℃)を入れたタンクの中に細
菌性白雲症に感染したコイを15尾入れ、カスガマイシ
ンを2%含有する飼料を7日間投与した。この場合力ス
ガマイシンの投与薬量(有効成分量二以下問じ)は魚体
重1kg当り0.2g、OoIgおよび0.05gとし
た。そして、さらに7日間清水(水温的22℃)中で飼
養した後、その#IN効果を調査した。その結果を第3
表に示した。Table 2 (Example 2) Fifteen carp infected with bacterial leukocoria were placed in a tank containing 50 ml of fresh water (water temperature: 22°C), and feed containing 2% kasugamycin was administered for 7 days. . In this case, the dose of sugamycin administered (the amount of active ingredient was 2 or less) was 0.2 g, OoIg and 0.05 g per 1 kg of fish weight. Then, after rearing in fresh water (water temperature: 22° C.) for another 7 days, the #IN effect was investigated. The result is the third
Shown in the table.
第 3 表
(実施例3)
50J1の清水を入れたタンクの中にカスガマイシンを
添加して濃度が0.01%gJ:び0− o。Table 3 (Example 3) Kasugamycin was added to a tank containing 50J1 of fresh water to a concentration of 0.01% gJ: and 0-o.
5%となるように溶解した。そして、そこへ水力と病に
感染したコイを50尾入れ、24時間薬浴させた。そし
て清水(水温的22℃)に戻して7日間飼養した後、そ
の治療効果を調査した。その結果を第4表に示した。It was dissolved to a concentration of 5%. Then, 50 carp infected with water and disease were placed there and bathed in medicine for 24 hours. The animals were then returned to fresh water (water temperature: 22°C) and reared for 7 days, after which the therapeutic effects were investigated. The results are shown in Table 4.
第4表
(実施例4)
50見の清水(水温的22℃)を入れたタンクの中に水
力と病に感染したコイを20尾入れ、カスガマイシンを
2%含有する飼料を7日間投与した。この場合力スガマ
イシンの投与薬量は、魚体重1kg当りO,Ig、0.
05gおよび0.025gとした。そして、さらに7日
間清水(水温的22℃)中で飼養した後、その治療効果
を調査した。その結果を第5表に示した。Table 4 (Example 4) Twenty carp infected with water and disease were placed in a tank containing 50 ml of fresh water (water temperature: 22°C), and fed with feed containing 2% kasugamycin for 7 days. In this case, the dose of sugamycin administered is O, Ig, 0.1 g/kg of fish weight.
05g and 0.025g. After raising the animals in fresh water (water temperature: 22° C.) for an additional 7 days, the therapeutic effects were investigated. The results are shown in Table 5.
第 5 表
(実施例5)
501の清水(水温的15℃)を入れたタンクの中に水
カビ病に感染したコイを20尾入れ、カスガマイシンを
2%含有する飼料を7日間投与した。この場合力スガマ
イシンの投与薬量は、魚体重1kg当り0.2gおよび
O,1gとした。そしてさらに7日間清水(水温的15
℃)中で飼養した後、その治療効果を調査した。その結
果を第6表に示した。Table 5 (Example 5) Twenty carp infected with water mold were placed in a tank containing 501 fresh water (water temperature: 15°C), and feed containing 2% kasugamycin was administered for 7 days. In this case, the dosage of sugamycin was 0.2 g and O.1 g per kg of fish weight. And for another 7 days with fresh water (water temperature: 15
℃), and its therapeutic effect was investigated. The results are shown in Table 6.
第6表Table 6
Claims (1)
ることを特徴とするコイの水かび病、細菌性白雲症防除
剤。A control agent for water mold and bacterial white cloud disease of carp, characterized by containing kasugamycin or its salts as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8824986A JPS61267521A (en) | 1986-04-18 | 1986-04-18 | Agent for controlling saprolegniasis and capsulated-pseudomonas disease of carp |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8824986A JPS61267521A (en) | 1986-04-18 | 1986-04-18 | Agent for controlling saprolegniasis and capsulated-pseudomonas disease of carp |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13843376A Division JPS5366441A (en) | 1976-11-19 | 1976-11-19 | Antibacterial agent for fish |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61267521A true JPS61267521A (en) | 1986-11-27 |
JPH0132209B2 JPH0132209B2 (en) | 1989-06-29 |
Family
ID=13937579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8824986A Granted JPS61267521A (en) | 1986-04-18 | 1986-04-18 | Agent for controlling saprolegniasis and capsulated-pseudomonas disease of carp |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61267521A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1982717A1 (en) * | 2007-04-20 | 2008-10-22 | Bayer CropScience AG | Use of fungicides for treating fish mycoses |
US8076328B2 (en) | 2007-04-20 | 2011-12-13 | Bayer Cropscience Ag | Use of fungicides for the treatment of fish mycoses |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5013789A (en) * | 1973-06-08 | 1975-02-13 | ||
JPS51138433A (en) * | 1975-05-26 | 1976-11-30 | Toshiba Corp | Method of coating photoresist |
-
1986
- 1986-04-18 JP JP8824986A patent/JPS61267521A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5013789A (en) * | 1973-06-08 | 1975-02-13 | ||
JPS51138433A (en) * | 1975-05-26 | 1976-11-30 | Toshiba Corp | Method of coating photoresist |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1982717A1 (en) * | 2007-04-20 | 2008-10-22 | Bayer CropScience AG | Use of fungicides for treating fish mycoses |
WO2008128654A3 (en) * | 2007-04-20 | 2008-12-18 | Bayer Cropscience Ag | Use of fungicides for treating fish mycoses |
US8076328B2 (en) | 2007-04-20 | 2011-12-13 | Bayer Cropscience Ag | Use of fungicides for the treatment of fish mycoses |
US8455481B2 (en) | 2007-04-20 | 2013-06-04 | Bayer Cropscience Ag | Use of fungicides for the treatment of fish mycoses |
Also Published As
Publication number | Publication date |
---|---|
JPH0132209B2 (en) | 1989-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tonguthai | Control of freshwater fish parasites: a Southeast Asian perspective | |
KR100193994B1 (en) | Medicinal feed for systemic treatment of external parasites and external bacterial diseases of fish | |
KR101544049B1 (en) | Compositions for preventing and curing Scuticocilliatosis scutica in a cultivated flounder | |
JP2008535901A (en) | Treatment of human and animal parasitic infections | |
CN103721240B (en) | Compound formulation for treating bacterial infection of digestive tract of livestock and poultry and preparation method of compound formulation | |
JPS61267521A (en) | Agent for controlling saprolegniasis and capsulated-pseudomonas disease of carp | |
KR100379026B1 (en) | Method for exterminating scutica in a cultivated flounder | |
KR19990022911A (en) | Insect repellent for aquaculture fish | |
Pawłowski et al. | Effect of mebendazole on hydatid cysts in pigs | |
JPS6137251B2 (en) | ||
RU2147237C1 (en) | Preparation for treatment of calves with colibacteriosis and method of its using | |
Phelps et al. | Control of external bacterial infections of bluegills with potassium permanganate | |
JPH0133447B2 (en) | ||
RU2808576C1 (en) | Method of treating bee colonies affected by associative infection with varroosis, american and european foulbrood | |
KR100358084B1 (en) | Treatment of gill monogenean disease in fish using praziquantel and cimetidine | |
JPS62221624A (en) | Prevention and treatment of viral disease of fish | |
RU2187314C1 (en) | Method for treating gastrointestinal diseases in fish | |
US3336190A (en) | Method of protecting the offspring of a herd of breeding swine from turbinate atrophy | |
US3422182A (en) | Method of treating an animal having demodectic mange | |
KR20010103486A (en) | Treatment agent of Scuticocilictida | |
RU1819612C (en) | Method of treatment and prophylaxis of bartonellosis in calves | |
RU2259843C1 (en) | Method for treating rabbits for myxomatosis | |
KR100563273B1 (en) | Drug Containing Terbinafine HCl for Prevention and Treatment of Scuticociliates Infestation in Cultured Fishes | |
UA135862U (en) | METHOD OF TREATMENT AND PREVENTION OF CRUSTACEOUS DISEASES OF FISH WITH THE HELP OF TRIFLUMURON | |
RU2060655C1 (en) | Method of parasite abolishment causing disease in aquarium fishes |